Sub-50 NM capsules for needle-free delivery of optimized veev DNA vaccine

Ended Definitive Contract Awarded Last action

Contract number
HDTRA114C0024
Awardee
Awarding agency
Obligated
$1,082,734

Award facts

Contract value 81% obligated
  • $1,082,734.00 Current, with exercised options
  • $1,334,476.00 Potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
NAICS code
541711 Research and Development in Biotechnology
PSC
AN92 R&D- Medical: Other (Applied Research/Exploratory Development)
Set-aside
No set-aside
Competition
Full and Open Competition · 33 offers Basic Research
Pricing
Cost Plus Fixed Fee
Place of performance
Chaska, MN 55318, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00004 · Base period $0
Other Administrative Action P00003 $0
Exercise an Option P00002 · Base period descr: if $531,085
Funding Only Action P00001 · Base period $276,649
Original award $275,000

Quick answers

Who was awarded contract HDTRA114C0024?

HDTRA114C0024 was awarded to Genesegues Inc. by Defense Threat Reduction Agency (Department of Defense) on March 1, 2014.

How much is contract HDTRA114C0024 worth?

The government has obligated $1,082,734 on HDTRA114C0024. Its potential value, with all options, is $1,334,476.

Was contract HDTRA114C0024 competed?

The extent of competition for HDTRA114C0024 was full and open competition. The government received 33 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award